NOTCH signaling roles in acute myeloid leukemia cell growth and interaction with other stemness-related signals

Anticancer Research

Volumn 34, Issue 11, 2014, Pages 6259-6264

  Tohda, Shuji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Acute myeloid leukaemia; HEDGEHOG; JAGGED; NOTCH; Review; WNT

Indexed keywords

BONE MORPHOGENETIC PROTEIN; DELTA LIKE PROTEIN 1; DELTA LIKE PROTEIN 3; DELTA LIKE PROTEIN 4; HYPOXIA INDUCIBLE FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER INHIBITION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL RENEWAL; GENE EXPRESSION; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; LIGAND BINDING; MYELOID LEUKEMIA CELL LINE; NONHUMAN; PATHOGENESIS; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL PROLIFERATION; METABOLISM; PATHOLOGY; STEM CELL;

ANIMALS; CELL PROLIFERATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84916212239     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Bigas A and Espinosa L: Hematopoietic stem cells: to be or Notch to be. Blood 119: 3226-3235, 2012.
2. Ntziachristos P, Lim JS, Sage J and Aifantis I: From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell 25: 318-334, 2014.
3. Espinoza I and Miele L: Notch inhibitors for cancer treatment. Pharmacol Ther 139: 95-110, 2013.
4. Weng AP, Ferrando AA, Lee W, Morris IV JP, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT and Aster JC: Activating mutations of NOTCH1 in human T-cell acute lymphoblastic leukemia. Science 306: 269-271, 2004.
5. Tohda S and Nara N: Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells. Leuk Lymphoma 42: 467-472, 2001.
6. Kanamori E, Itoh M, Tojo N, Koyama T, Nara N and Tohda S: Flow cytometric analysis of Notch1 and Jagged1 expression in normal blood cells and leukemia cells. Exp Ther Med 4: 397-400, 2012.
7. Fu L, Kogoshi H, Nara N and Tohda S: NOTCH1 mutations are rare in acute myeloid leukemia. Leuk Lymphoma 47: 2400-2403, 2006.
8. Wouters BJ, Jordà MA, Keeshan K, Louwers I, Erpelinck-Verschueren CA, Tielemans D, Langerak AW, He Y, Yashiro-Ohtani Y, Zhang P, Hetherington CJ, Verhaak RG, Valk PJ, Löwenberg B, Tenen DG, Pear WS and Delwel R: Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1 . Blood 110: 3706-3714, 2007.
9. Fu L, Nara N and Tohda S: Involvement of Notch signaling in myelodysplastic syndrome. Leuk Res 31: 1160-1161, 2007.
10. Palomero T, McKenna K, O-Neil J, Galinsky I, Stone R, Suzukawa K, Stiakaki E, Kalmanti M, Fox EA, Caligiuri MA, Aster JC, Look AT and Ferrando AA: Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias. Leukemia 20: 1963-1966, 2006.
11. Tohda S, Sakano S, Ohsawa M, Murakami N and Nara N: A novel cell line derived from de novo acute myeloblastic leukemia with trilineage myelodysplasia which proliferates in response to a NOTCH ligand, Delta-1 protein. Br J Haematol 117 : 373-378, 2002.
12. Tohda S, Murata-Ohsawa M, Sakano S and Nara N: Notch ligands, Delta-1 and Delta-4 suppress the self-renewal capacity and long-term growth of two myeloblastic leukemia cell lines. Int J Oncol 22: 1073-1079, 2003.
13. Murata-Ohsawa M, Tohda S and Nara N: Cellular analysis of growth suppression induced by the Notch ligands, Delta-1 and Jagged-1 in two myeloid leukemia cell lines. Int J Mol Med 14: 223-226, 2004.
14. Tohda S, Kogoshi H, Murakami N, Sakano S and Nara N: Diverse effects of the Notch ligands Jagged1 and Delta1 on the growth and differentiation of primary acute myeloblastic leukemia cells. Exp Hematol 33: 558-563, 2005.
15. Lobry C, Ntziachristos P, Ndiaye-Lobry D, Oh P, Cimmino L, Zhu N, Araldi E, Hu W, Freund J, Abdel-Wahab O, Ibrahim S, Skokos D, Armstrong SA, Levine RL, Park CY and Aifantis I: Notch pathway activation targets AML-initiating cell homeostasis and differentiation. J Exp Med 210: 301-319, 2013.
16. Kannan S, Sutphin RM, Hall MG, Golfman LS, Fang W, Nolo RM, Akers LJ, Hammitt RA, McMurray JS, Kornblau SM, Melnick AM, Figueroa ME and Zweidler-McKay PA: Notch activation inhibits AML growth and survival: a potential therapeutic approach. J Exp Med 210: 321-337, 2013.
17. Kode A, Manavalan JS, Mosialou I, Bhagat G, Rathinam CV, Luo N, Khiabanian H, Lee A, Murty VV, Friedman R, Brum A, Park D, Galili N, Mukherjee S, Teruya-Feldstein J, Raza A, Rabadan R, Berman E and Kousteni S: Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts. Nature 506: 240-244, 2014.
18. Murata-Ohsawa M, Tohda S, Kogoshi H, Sakano S and Nara N: The Notch ligand, Delta-1, alters retinoic acid (RA)-induced neutrophilic differentiation into monocytic and reduces RAinduced apoptosis in NB4 cells. Leuk Res 29: 197-203, 2005.
19. Grieselhuber NR, Klco JM, Verdoni AM, Lamprecht T, Sarkaria SM, Wartman LD and Ley TJ: Notch signaling in acute promyelocytic leukemia. Leukemia 27: 1548-1557, 2013.
20. Murata-Ohsawa M, Tohda S, Kogoshi H and Nara N: The Notch ligand, Delta-1, reduces TNF-alpha-induced growth suppression and apoptosis by decreasing activation of caspases in U937 cells. Int J Mol Med 14: 861-866, 2004.
21. Adamia S, Bar-Natan M, Haibe-Kains B, Pilarski PM, Bach C, Pevzner S, Calimeri T, Avet-Loiseau H, Lode L, Verselis S, Fox EA, Galinsky I, Mathews S, Dagogo-Jack I, Wadleigh M, Steensma DP, Motyckova G, Deangelo DJ, Quackenbush J, Tenen DG, Stone RM and Griffin JD: NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML. Blood 123: 2816-2825, 2014.
22. Fu L, Katsube K and Tohda S: Transition of cleaved Notch1 and gene expression changes in myeloblastic leukemia cells stimulated with notch ligands. Anticancer Res 29: 3967-3970, 2009.
23. Itoh M, Fu L and Tohda S: NF-κB activation induced by Notch ligand stimulation in acute myeloid leukemia cells. Oncol Rep 22:631-634, 2009.
24. Okuhashi Y, Nara N and Tohda S: Effects of γ-secretase inhibitors on the growth of leukemia cells. Anticancer Res 30: 495-498, 2010.
25. Kopan R and Ilagan MXG: γ-Secretase: proteasome of the membrane? Nat Rev Mol Cell Biol 5: 499-504, 2004.
26. Okuhashi Y, Itoh M, Arai A, Nara N and Tohda S: γ-Secretase inhibitors induce erythroid differentiation in erythroid leukemia cell lines. Anticancer Res 30: 4071-4074, 2010.
27. Okuhashi Y, Itoh M, Nara N and Tohda S: NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells. Anticancer Res 33: 4293-4298, 2013.
28. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R and Weissman IL: A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423: 409-414, 2003.
29. Kawaguchi-Ihara N, Murohashi I, Nara N and Tohda S: Promotion of the self-renewal capacity of human acute leukemia cells by WNT3A. Anticancer Res 28: 2701-2704, 2008.
30. Kawahara T, Kawaguchi-Ihara N, Okuhashi Y, Itoh M, Nara N and Tohda S: Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. Anticancer Res 29 : 4629-4632, 2009.
31. Okuhashi Y, Itoh M, Nara N and Tohda S: Effects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cells. Anticancer Res 31: 893-896, 2011.
32. Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, Chadwick K, Ling LE, Karanu FN and Bhatia M: Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2: 172-180, 2001.
33. Kawaguchi-Ihara N, Okuhashi Y, Itoh M, Murohashi I, Nara N and Tohda S: Promotion of the self-renewal capacity of human leukemia cells by sonic hedgehog protein. Anticancer Res 31: 781-784, 2011.
34. Chapuis N, Tamburini J, Green AS, Willems L, Bardet V, Park S, Lacombe C, Mayeux P and Bouscary D: Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies. Leukemia 24: 1686-1699, 2010.
35. Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, Caparros E, Buteau J, Brown K, Perkins SL, Bhagat G, Agarwal AM, Basso G, Castillo M, Nagase S, Cordon-Cardo C, Parsons R, Zúñiga-Pflücker JC, Dominguez M and Ferrando AA: Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13: 1203-1210, 2007.
36. Ono A, Oike R, Okuhashi Y, Takahashi Y, Itoh M, Nara N and Tohda S: Comparative effects of PP242 and rapamycin on mTOR signalling and NOTCH signalling in leukemia cells. Anticancer Res 33: 809-813, 2013.
37. Wang Y, Liu Y, Malek SN, Zheng P and Liu Y: Targeting HIF1α eliminates cancer stem cells in hematological malignancies. Cell Stem Cell 8: 399-411, 2011.
38. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U and Bondesson M: Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9: 617-628, 2005.
39. Yonekura S, Itoh M, Okuhashi Y, Takahashi Y, Ono A, Nara N and Tohda S: Effects of the HIF1 inhibitor, echinomycin, on growth and NOTCH signalling in leukaemia cells. Anticancer Res 33: 3099-3103, 2013.
40. Goldman DC, Bailey AS, Pfaffle DL, Al Masri A, Christian JL and Fleming WH: BMP4 regulates the hematopoietic stem cell niche. Blood 114: 4393-4401, 2009.
41. Takahashi Y, Ishigaki T, Okuhashi Y, Ono A, Itoh M, Nara N and Tohda S: Effect of BMP4 on the growth and clonogenicity of human leukemia and lymphoma cells. Anticancer Res 32: 2813-2817, 2012.
42. Kogoshi H, Sato T, Koyama T, Nara N and Tohda S: ã-Secretase inhibitors suppress the growth of leukemia and lymphoma cells. Oncol Rep 18: 77-80, 2007.
43. del Álamo D, Rouault H and Schweisguth F: Mechanism and significance of cis-inhibition in Notch signalling. Curr Biol 21: R40-47, 2011.
44. Takeuchi H and Haltiwanger RS: Role of glycosylation of Notch in development. Semin Cell Dev Biol 21: 638-645, 2010.
45. Andersen P, Uosaki H, Shenje LT and Kwon C: Non-canonical Notch signaling: emerging role and mechanism. Trends Cell Biol 22: 257-265, 2012.
46. Dallas MH, Varnum-Finney B, Delaney C, Kato K and Bernstein ID: Density of the Notch ligand Delta1 determines generation of B- and T-cell precursors from hematopoietic stem cells. J Exp Med 201: 1361-1366, 2005.
47. Chiang MY, Shestova O, Xu L, Aster JC and Pear WS: Divergent effects of supraphysiologic Notch signals on leukemia stem cells and hematopoietic stem cells. Blood 121: 905-917, 2013.
48. Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, Buonamici S, van De Walle I, Cathelin S, Trimarchi T, Araldi E, Liu C, Ibrahim S, Beran M, Zavadil J, Efstratiadis A, Taghon T, Michor F, Levine RL and Aifantis I: A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature 473: 230-233, 2011.